nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.03.2008 | Case report

Targeted delivery of TNF using NGR-TNF in combination with chemotherapy as an effective and tolerable strategy in a hepatocarcinoma patient

verfasst von: M. Giovannini, V. Gregorc, M. G. Viganò, E. Roca, C. Lazzari, A. Spreafico, C. Belli, G. Citterio, G. Rossoni, G. Donadoni, A. Corti, E. Villa, F. C. Cappio

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Vorheriger Artikel Complete cytogenetic remission in a patient with FIP1L1-PDGFRA fusion negative chronic eosinophilic leukemia associated with atypical thrombotic events

Nächster Artikel Announcement

Titel: Targeted delivery of TNF using NGR-TNF in combination with chemotherapy as an effective and tolerable strategy in a hepatocarcinoma patient
verfasst von: M. Giovannini
V. Gregorc
M. G. Viganò
E. Roca
C. Lazzari
A. Spreafico
C. Belli
G. Citterio
G. Rossoni
G. Donadoni
A. Corti
E. Villa
F. C. Cappio
Publikationsdatum: 01.03.2008
Verlag: Springer-Verlag
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 1/2008
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-008-0011-8

Springer Medizin Österreich

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2008

Future perspectives in the treatment of pancreatic cancer

Visions have been realised

memo – New official Journal of CECOG

Chemotherapy plus bevacizumab in the first-line treatment of non-small cell lung cancer: benefits, risks and limitations

Mechanisms of tumour vascularisation

Angiogenesis and anti-angiogenesis in haematological diseases